000 01385 a2200385 4500
005 20250512005857.0
264 0 _c19891219
008 198912s 0 0 eng d
022 _a0065-1591
024 7 _a10.1111/j.1600-0447.1989.tb06433.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWiesel, F A
245 0 0 _aClinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET.
_h[electronic resource]
260 _bActa psychiatrica Scandinavica. Supplementum
_c1989
300 _a30-4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xpharmacokinetics
650 0 4 _aButyrophenones
_xpharmacokinetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aProlactin
_xblood
650 0 4 _aPsychotic Disorders
_xblood
650 0 4 _aRaclopride
650 0 4 _aReceptors, Dopamine
650 0 4 _aReceptors, Dopamine D2
650 0 4 _aSalicylamides
650 0 4 _aSchizophrenia
_xblood
650 0 4 _aTomography, Emission-Computed
700 1 _aFarde, L
700 1 _aHalldin, C
773 0 _tActa psychiatrica Scandinavica. Supplementum
_gvol. 352
_gp. 30-4
856 4 0 _uhttps://doi.org/10.1111/j.1600-0447.1989.tb06433.x
_zAvailable from publisher's website
999 _c2579180
_d2579180